Use of lozenges containing Lactobacillus brevis CD2 in recurrent aphthous stomatitis: a double-blind placebo-controlled trial
… The primary aim of this study was to evaluate the efficacy and time to remission with a lozenge containing at least 1 billion Lactobacillus brevis CD2 in patients with a clinical condition …..... Read More